![](/img/cover-not-exists.png)
Quality of life in cutaneous T cell lymphoma patients treated with the anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat: Results from MAVORIC
Porcu, Pierluigi, Hudgens, Stacie, Quaglino, Pietro, Cowan, Richard, Floden, Lysbeth, Tsianakas, Athanasios, Leoni, Mollie, Dale, Stephen, Duvic, MadelineVolume:
101
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2018.07.309
Date:
September, 2018
File:
PDF, 61 KB
english, 2018